Citius Pharmaceuticals is trading at $0.52 (8.2%) up today as the stock rebounds from several weak sessions last week.
- The pre-market strength appears to be a technical bounce in a volatile micro-cap name rather than a reaction to new information.
- There are no fresh company-specific news, earnings, or regulatory updates tied directly to this move.
- The latest noted action was the stock trading down on July 20, 2026, which also occurred without a clear catalyst.